The Belgian company Amnovis, specialized in additively manufactured medical devices and high-performance components, celebrates its fifth anniversary and the shipment of its 100,000th 3D-printed implant. Founded in 2020 by Peter Mercelis and Ruben Wauthle, Amnovis has quickly established itself as a reliable partner in highly regulated industries. The company focuses on quality assurance, traceability, and precise process control—key factors in the additive manufacturing of medical components.
The milestone implant was a U.S. FDA-approved SI fixation system from manufacturer Promethean Restorative. By leveraging its own FDA Master File, Amnovis was able to accelerate the approval process for its customer.
“From day one, we wanted Amnovis to be more than just another supplier,” said Ruben Wauthle, CEO and Co-founder of Amnovis. “We set out to build a company that consistently delivers high-quality parts, communicates transparently, and meets deadlines. Five years later, we’re proud to say we’re doing exactly that.”
The results speak for themselves: a customer acceptance rate of over 99.9 percent and an on-time delivery rate of more than 90 percent over the past three years.
In addition to medical technology, Amnovis increasingly produces components for applications in aerospace, semiconductor manufacturing, and mechanical engineering. To meet growing demand, the company is currently expanding its production capacities.
“Innovation is in our DNA,” Wauthle added. “We don’t just follow trends. We redefine the state-of-the-art in 3D printing by bridging the gap between emerging technologies and scalable, real-world applications. That’s what sets Amnovis apart.”
Technologically, Amnovis focuses on advancements within the Laser Powder Bed Fusion (L-PBF) process. These include heat-treatment-free titanium alloys, patented deformable implants for patient-specific adaptation, and the “CuperNova” process for improved processing of copper alloys. Research into multi-metal printing technologies is also at an advanced stage.
“As we look ahead, we’re excited about the opportunities to scale our impact even further,” Wauthle concluded. “We’re building on a solid foundation of quality and reliability, and we’re committed to turning cutting-edge ideas into real-world solutions for our customers.”
With this, Amnovis positions itself as a technically focused development partner in industrial 3D printing production.
Subscribe to our Newsletter
3DPresso is a weekly newsletter that links to the most exciting global stories from the 3D printing and additive manufacturing industry.
